Mona Mofid is a Dermatology physician. OpenAlex indexes 10 publications with 262 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
25 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Incyte CorporationProgram year202514 payments
- Galderma Laboratories, L.P.Program year20256 payments
- Arcutis Biotherapeutics, Inc.Program year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
36.1%Corticosteroid23.4%Triamcinolone Acetonide89%Fluocinolone Acetonide11%Part D<11 patientsAntivirals12.7%Imiquimod100%Part D≥47 patientsCancer & immunology
23%Nucleoside Metabolic Inhibitor10.7%Fluorouracil100%Part D≥55 patientsRetinoid5.5%Tretinoin100%Part D≥13 patients+ 3 more classes in this area
Anti-infectives
21.7%Tetracycline-class Drug9%Doxycycline Hyclate74%Doxycycline Monohydrate26%Part D<11 patientsAzole Antifungal4.2%Ketoconazole100%Part D≥12 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Lymph node biopsy results for desmoplastic malignant melanoma.
PubMed
2007 - Case of the month: June's diagnosis. Chronic tophaceous gout2004
- Case of the Month: Dermatology2004
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”